Skip to main content
TipRanks
Go Ultimate75% OFF

Kairos Pharma, Ltd. (KAPA) Income Statement

180 Followers

Kairos Pharma, Ltd. Income Statement

Last quarter (Q3 2026), Kairos Pharma, Ltd.'s total revenue was $0.00. In Q3, Kairos Pharma, Ltd.'s net income was $-1.98M. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ -160.00K$ -160.00K$ -160.00K$ -98.00K
$ 5.57M$ 2.18M$ 1.55M$ 411.00K$ 1.84M
Depreciation and Amortization$ 160.00K$ 160.00K$ 160.00K$ 160.00K$ 98.00K
$ -5.29M$ -1.58M$ -1.55M$ -411.00K$ -1.84M
$ -5.57M$ -2.34M$ -1.71M$ -571.00K$ -1.94M
$ 125.00K$ -260.00K$ -98.00K$ -479.00K$ -202.00K
$ -5.45M$ -2.60M$ -1.81M$ -1.05M$ -2.15M
$ -5.45M$ -2.60M$ -1.81M$ -1.05M$ -2.15M
Per Share Metrics
Basic EPS$ -2.10$ -1.61$ -1.19$ -0.70$ -1.19
Diluted EPS$ -2.10$ -1.61$ -1.19$ -0.70$ -1.19
Weighted Average Shares Outstanding2.63M1.62M1.48M1.46M1.83M
Weighted Average Shares Outstanding (Diluted)2.63M1.62M1.48M1.46M1.83M

Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

-6M-4M-2M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin